Epoch Investment Partners Inc. Cuts Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Epoch Investment Partners Inc. decreased its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 6.2% in the first quarter, Holdings Channel reports. The institutional investor owned 29,522 shares of the medical instruments supplier’s stock after selling 1,950 shares during the period. Epoch Investment Partners Inc.’s holdings in DENTSPLY SIRONA were worth $980,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Gabelli Funds LLC increased its holdings in DENTSPLY SIRONA by 0.4% in the first quarter. Gabelli Funds LLC now owns 217,000 shares of the medical instruments supplier’s stock valued at $7,202,000 after buying an additional 800 shares in the last quarter. Toronto Dominion Bank increased its stake in shares of DENTSPLY SIRONA by 11.0% during the first quarter. Toronto Dominion Bank now owns 99,358 shares of the medical instruments supplier’s stock worth $3,298,000 after purchasing an additional 9,824 shares in the last quarter. Advisors Asset Management Inc. increased its stake in shares of DENTSPLY SIRONA by 99.3% during the first quarter. Advisors Asset Management Inc. now owns 14,548 shares of the medical instruments supplier’s stock worth $483,000 after purchasing an additional 7,248 shares in the last quarter. Boulder Hill Capital Management LP purchased a new stake in shares of DENTSPLY SIRONA during the first quarter worth about $249,000. Finally, UniSuper Management Pty Ltd increased its stake in shares of DENTSPLY SIRONA by 1,153.6% during the first quarter. UniSuper Management Pty Ltd now owns 26,126 shares of the medical instruments supplier’s stock worth $867,000 after purchasing an additional 24,042 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 3,577 shares of DENTSPLY SIRONA stock in a transaction on Friday, May 31st. The shares were bought at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the acquisition, the director now directly owns 58,374 shares in the company, valued at $1,631,553.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.52% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have recently commented on XRAY shares. Evercore ISI cut their target price on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, July 9th. Needham & Company LLC dropped their price objective on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a research note on Friday, May 3rd. Piper Sandler reaffirmed a “neutral” rating and set a $32.00 price objective (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Finally, StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has an average rating of “Moderate Buy” and a consensus price target of $33.67.

DENTSPLY SIRONA Trading Down 0.1 %

Shares of XRAY stock traded down $0.02 during trading hours on Friday, hitting $26.41. The company had a trading volume of 1,748,732 shares, compared to its average volume of 2,495,531. The company’s fifty day moving average is $26.32 and its 200 day moving average is $30.43. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. DENTSPLY SIRONA Inc. has a fifty-two week low of $23.94 and a fifty-two week high of $41.65. The stock has a market capitalization of $5.48 billion, a PE ratio of -60.02, a price-to-earnings-growth ratio of 1.18 and a beta of 1.01.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The firm had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same period in the prior year, the business posted $0.39 EPS. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. Research analysts expect that DENTSPLY SIRONA Inc. will post 2.02 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, July 12th. Shareholders of record on Friday, June 28th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, June 28th. This represents a $0.64 dividend on an annualized basis and a yield of 2.42%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.